Skip to main content
Equibles

JANE STREET GROUP, LLC

Position in RPRX — Royalty Pharma plc

CIK 1595888 NEW YORK, NY
Back to RPRX Full portfolio

Position in RPRX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$2,997,501
-$112,148,823 QoQ
Shares Held
53,460
-97.8% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#246
of 646 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in RPRX Over Time

Shares Held

Position Value (USD)

Derivatives in RPRX

reported options exposure · as of Jun 30, 2026
CallValue
$7,675,983
CallShares
136,900
PutValue
$6,846,147
PutShares
122,100

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

JANE STREET GROUP, LLC holds $1,372,940,661 across 293 Biotechnology names. RPRX ranks #50 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 BBIO
BridgeBio Pharma, Inc.
 2,934,193 $218,538,693
2 MDGL
Madrigal Pharmaceuticals, Inc.
 191,541 $102,847,939
3 AXSM
Axsome Therapeutics, Inc.
 403,995 $98,885,855
4 TGTX
Tg Therapeutics, Inc.
 1,752,646 $96,290,370
5 EXEL
Exelixis, Inc.
 1,402,438 $76,306,651
6 QURE
uniQure N.V.
 1,610,483 $74,178,846
7 HALO
Halozyme Therapeutics, Inc.
 694,684 $54,372,915
8 TVTX
Travere Therapeutics, Inc.
 938,699 $53,327,489

All Filings in RPRX

Export CSV
49 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $6,846,147 122,100
2026-06-30 $7,675,983 136,900
2026-06-30 $2,997,501 53,460
2026-03-31 $115,146,324 2,400,382
2026-03-31 $8,524,269 177,700
2026-03-31 $9,325,368 194,400
2025-12-31 $2,159,976 55,900
2025-12-31 $191,167,882 4,947,409
2025-12-31 $1,522,416 39,400
2025-09-30 $6,145,776 174,200
2025-09-30 $111,190,564 3,151,660
2025-06-30 $2,280,699 63,300
2025-06-30 $27,387,194 760,122
2025-06-30 $6,813,273 189,100
2025-03-31 $33,127,704 1,064,173
2025-03-31 $205,458 6,600
2025-03-31 $4,818,924 154,800
2024-12-31 $2,178,554 85,400
2024-12-31 $7,268,486 284,927
2024-09-30 $2,215,107 78,300
2024-09-30 $5,822,251 205,806
2024-06-30 $7,473,705 283,417
2024-03-31 $2,733,329 90,001
2023-12-31 $11,720,804 417,259
2023-09-30 $2,027,303 74,698
2023-06-30 $3,938,930 128,137
2023-03-31 $1,345,107 37,333
2022-12-31 $1,099,288 27,816
2022-09-30 $749,357 18,650
2022-06-30 $243,411 5,790
2022-03-31 $8,497,176 218,100
2022-03-31 $958,416 24,600
2022-03-31 $248,253 6,372
2021-12-31 $3,733,945 93,700
2021-12-31 $13,477,270 338,200
2021-12-31 $1,369,205 34,359
2021-09-30 $1,466,019 40,565
2021-09-30 $14,900,522 412,300
2021-09-30 $4,358,484 120,600
2021-06-30 $4,894,206 119,400
2021-06-30 $405,801 9,900
2021-06-30 $2,980,259 72,707
2021-03-31 $331,512 7,600
2021-03-31 $821,669 18,837
2021-03-31 $21,661,692 496,600
2020-12-31 $309,859 6,191
2020-12-31 $7,032,025 140,500
2020-09-30 $563,738 13,400
2020-06-30 $2,059,733 42,425